Invenomic Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Universal Health Services
UHS
|
+$49M |
| 2 |
Comcast
CMCSA
|
+$38.6M |
| 3 |
Warner Bros
WBD
|
+$37.1M |
| 4 |
IS
ironSource Ltd.
IS
|
+$22.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$22.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
H&R Block
HRB
|
+$19.8M |
| 2 |
CVSA
Covista Inc
CVSA
|
+$16.9M |
| 3 |
PayPal
PYPL
|
+$12.3M |
| 4 |
GAP
The Gap Inc
GAP
|
+$8.17M |
| 5 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$6.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.26% |
| 2 | Consumer Discretionary | 13.68% |
| 3 | Communication Services | 11.41% |
| 4 | Industrials | 8.15% |
| 5 | Healthcare | 7.69% |
Similar funds
Invenomic Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Invenomic Capital Management held 199 positions worth $1.41B, up 51% from $937M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Invenomic Capital Management deployed $625M of net new capital in Q2 2022, opening 45 new positions and adding to 81 existing holdings. Its largest new stake was Comcast: 899,399 shares worth $35.3M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was H&R Block, an estimated $19.8M trimmed.
- Invenomic Capital Management's largest Q2 2022 buy was Comcast: 899,399 shares worth $35.3M.
- Invenomic Capital Management added most to Universal Health Services in Q2 2022, an estimated $49M increase.
- Invenomic Capital Management's biggest Q2 2022 reduction was H&R Block, cutting an estimated $19.8M.
- Invenomic Capital Management fully exited PayPal in Q2 2022, selling an estimated $12.3M.
- Invenomic Capital Management's ten largest holdings make up 33% of its $1.41B portfolio in Q2 2022.
- Invenomic Capital Management opened 45 new positions and closed 52 in Q2 2022.
- Invenomic Capital Management's portfolio value rose 51% quarter-over-quarter to $1.41B.
Based on Invenomic Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.